
STRW Stock Forecast & Price Target
STRW Analyst Ratings
Bulls say
Strawberry Fields REIT is attractive because it trades at a steep discount to broader healthcare REIT peers and the sector, yet its valuation is supported by improving cash-flow visibility, a raised reNAV/sh estimate of $17.00, and a measured leverage profile relative to its size. The company’s fundamentals are strengthened by a roughly 5% dividend yield with only about a 50% AFFO payout ratio, around $40 million of free cash flow after dividends, and management’s ability to fund growth despite about $250 million of debt expiring in 2026. Its acquisition pipeline has also expanded to $325 million and recent transactions, including an $8.6 million hospital campus deal folded into an existing master lease at a 10% initial yield, reinforce disciplined capital deployment and support future earnings growth.
Bears say
Strawberry Fields REIT is exposed to weak governance alignment because concentrated insider ownership and management-linked operating partnership units can limit minority shareholders’ influence while giving insiders meaningful control over decisions. Its tenant base is highly vulnerable to reimbursement cuts, compliance costs, litigation, and operational stress, and with nearly half of the leased portfolio tied to senior managers’ commercial interests, tenant distress, defaults, or bankruptcies could quickly pressure rent collections and the in-place distribution. The balance sheet and growth outlook also look fragile because rising interest rates, floating-rate debt, significant lease expirations in the next three years, and limited liquidity could force dilutive equity, costly refinancing, or fire-sale asset disposals.
This aggregate rating is based on analysts' research of Strawberry Fields REIT Ltd and is not a guaranteed prediction by Public.com or investment advice.
STRW Analyst Forecast & Price Prediction
Start investing in STRW
Order type
Buy in
Order amount
Est. shares
0 shares